Biocure Technology Inc.
CUREX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 704.60K | 742.10K | 768.00K | 775.20K | 451.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 704.60K | 742.10K | 768.00K | 775.20K | 451.70K |
| Operating Income | -704.60K | -742.10K | -768.00K | -775.20K | -451.70K |
| Income Before Tax | -2.96M | -3.04M | -1.03M | -1.08M | 1.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.96 | -3.04 | -1.03 | -1.08 | 1.81 |
| Earnings from Discontinued Operations | -26.80K | -26.80K | -74.80K | -256.40K | -623.50K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.10K | 2.10K | 9.40K | 20.20K | 25.80K |
| Net Income | -2.99M | -3.06M | -1.10M | -1.31M | 1.21M |
| EBIT | -704.60K | -742.10K | -768.00K | -775.20K | -451.70K |
| EBITDA | -- | -- | -- | -- | -291.20K |
| EPS Basic | -0.33 | -0.33 | -0.15 | -0.17 | 0.12 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.05 | -0.05 | -0.02 |
| EPS Diluted | -0.33 | -0.33 | -0.15 | -0.17 | 0.12 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.05 | -0.05 | -0.02 |
| Average Basic Shares Outstanding | 110.04M | 119.14M | 121.18M | 122.96M | 125.89M |
| Average Diluted Shares Outstanding | 110.04M | 119.14M | 121.18M | 122.96M | 125.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |